Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3233/HAB-200441 http://scihub22266oqcxt.onion/10.3233/HAB-200441 33998533!ä!33998533 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Antibodies 2021 ; 29 (3): 179-191 Nephropedia Template TP {{tp|p=33998533|t=2021. A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection |pdf=|usr=}}{{33998533}} gab.com Text A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection JO: Hum Antibodies http://www.kidney.de/pget.php?&tw=1&pmid=33998533 #FOAvip The harmful COVID-19 pandemic caused by the SARS-CoV-2 coronavirus imposes the scientific community to develop or find conventional curative drugs, protective vaccines, or passive immune strategies rapidly and efficiently. Passive immunity is based on recovering hyper-immune plasma from convalescent patients, or monoclonal antibodies with elevated titer of neutralizing antibodies with high antiviral activity, that have potential for both treatment and prevention. In this review, we focused on researching the potentiality of monoclonal antibodies for the prevention and treatment of COVID-19 infection. Our research review includes antibody-based immunotherapy, using human monoclonal antibodies targeting SARS-CoV-2 viral protein regions, specifically the spike protein regions, and using hyper-immune plasma from convalescent COVID-19 patients, in which monoclonal antibodies act as immunotherapy for the cytokine storm syndrome associated with the COVID-19 infection. In addition, we will demonstrate the role of the monoclonal antibodies in the development of candidate vaccines for SARS-CoV-2. Moreover, the recent progress of the diagnostic mouse monoclonal antibodies' role will be highlighted, as an accurate and rapid diagnostic assay, in the antigen detection of SARS-CoV-2. In brief, the monoclonal antibodies are the potential counter measures that may control SARS-CoV-2, which causes COVID-19 disease, through immunotherapy and vaccine development, as well as viral detection. Twit Text FOAVip A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection ????Hum Antibodies http://www.kidney.de/pget.php?&tw=1&pmid=33998533 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33998533 #FOAvip English Wikipedia <ref>{{Cite pmid|33998533}}</ref> A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection #MMPMID33998533 Tabll AA; Shahein YE; Omran MM; Elnakib MM; Ragheb AA; Amer KE Hum Antibodies 2021[]; 29 (3): 179-191 PMID33998533show ga The harmful COVID-19 pandemic caused by the SARS-CoV-2 coronavirus imposes the scientific community to develop or find conventional curative drugs, protective vaccines, or passive immune strategies rapidly and efficiently. Passive immunity is based on recovering hyper-immune plasma from convalescent patients, or monoclonal antibodies with elevated titer of neutralizing antibodies with high antiviral activity, that have potential for both treatment and prevention. In this review, we focused on researching the potentiality of monoclonal antibodies for the prevention and treatment of COVID-19 infection. Our research review includes antibody-based immunotherapy, using human monoclonal antibodies targeting SARS-CoV-2 viral protein regions, specifically the spike protein regions, and using hyper-immune plasma from convalescent COVID-19 patients, in which monoclonal antibodies act as immunotherapy for the cytokine storm syndrome associated with the COVID-19 infection. In addition, we will demonstrate the role of the monoclonal antibodies in the development of candidate vaccines for SARS-CoV-2. Moreover, the recent progress of the diagnostic mouse monoclonal antibodies' role will be highlighted, as an accurate and rapid diagnostic assay, in the antigen detection of SARS-CoV-2. In brief, the monoclonal antibodies are the potential counter measures that may control SARS-CoV-2, which causes COVID-19 disease, through immunotherapy and vaccine development, as well as viral detection. |*COVID-19 Drug Treatment[MESH] |*Immunization, Passive[MESH] |Antibodies, Monoclonal/immunology/*therapeutic use[MESH] |Antibodies, Neutralizing/immunology/therapeutic use[MESH] |Antibodies, Viral/immunology/therapeutic use[MESH] |COVID-19 Vaccines/*immunology[MESH] |COVID-19/immunology[MESH] |Humans[MESH] |Pandemics[MESH]A review of monoclonal antibodies in COVID-19: Role in immunotherapy, (epmc).pdf DeepDyve Pubget Overpricing